[Federal Register Volume 87, Number 119 (Wednesday, June 22, 2022)]
[Notices]
[Pages 37340-37341]
[FR Doc No: 2022-13341]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

[Docket No. USCG-2022-0393]

National Maritime Security Advisory Committee; July 2022 Virtual
Meeting

AGENCY: U.S. Coast Guard, Department of Homeland Security.

ACTION: Notice of Federal Advisory Committee virtual meeting.

-----------------------------------------------------------------------

SUMMARY: The National Maritime Security Advisory Committee (Committee)
will conduct a virtual meeting, to review and discuss matters relating
to national maritime security. Specifically, the Coast Guard intends to
present and issue a task focused on improving and enhancing the sharing
of information related to cybersecurity risks that may cause a
transportation security incident. This virtual meeting will be open to
the public.

DATES:
    Meeting: The Committee will meet virtually on Tuesday, July 12,
2022 from 1 p.m. until 3 p.m. Eastern Daylight Time (EDT). This virtual
meeting may close early if all business is finished.
    Comments and supporting documentation: To ensure your

comments are received by Committee members before the virtual meeting,
submit your written comments no later than July 8, 2022.

ADDRESSES: To join the virtual meeting or to request special
accommodations, contact the individual listed in the FOR FURTHER
INFORMATION CONTACT section no later than 1 p.m. EDT on July 8, 2022,
to obtain the needed information. The number of virtual lines are
limited and will be available on a first-come, first-served basis.
    The National Maritime Security Advisory Committee is committed to
ensuring all participants have equal access regardless of disability
status. If you require reasonable accommodation due to a disability to
fully participate, please call or email the individual in the FOR
FURTHER INFORMATION CONTACT section of this document as soon as
possible.
    Instructions: You are free to submit comments at any time,
including orally at the meeting as time permits, but if you want
Committee members to review your comment before the meeting, please
submit your comments no later than July 8, 2022. We are particularly
interested in comments on the issues in the ``Agenda'' section below.
We encourage you to submit comments through Federal eRulemaking Portal
at https://regulations.gov. If your material cannot be submitted using
https://www.regulations.gov, call or email the individual in the FOR
FURTHER INFORMATION CONTACT section of this document for alternate
instructions. You must include the docket number [USCG- 2022-0393].
Comments received will be posted without alteration at https://www.regulations.gov including any personal information provided. You
may wish to read the Privacy and Security Notice found via a link on
the homepage of https://www.regulations.gov. For more about the privacy
and submissions in response to this document, see DHS's eRulemaking
System of Records notice (85 FR 14226, March 11, 2020). If you
encounter technical difficulties with comment submission, contact the
individual listed in the FOR FURTHER INFORMATION CONTACT section of
this notice.
    Docket Search: Documents mentioned in this notice as being
available in the docket, and all public comments, will be in our online
docket at https://www.regulations.gov, and can be viewed by following
that website's instructions. Additionally, if you go to the online
docket and sign-up for email alerts, you will be notified when comments
are posted.

FOR FURTHER INFORMATION CONTACT: Mr. Ryan Owens, Alternate Designated
Federal Officer of the National Maritime Security Advisory Committee,
2703 Martin Luther King Jr. Avenue SE, Washington, DC 20593, Stop 7581,
Washington, DC 20593-7581; telephone<PHONE_NUMBER> or email
[email protected].

SUPPLEMENTARY INFORMATION: Notice of this meeting is in compliance with
the Federal Advisory Committee Act, (5, U. S. C., Appendix). The
Committee was established on December 4, 2018, by Sec.  602 of the
Frank LoBiondo Coast Guard Authorization Act of 2018, Public Law 115-
282, 132 Stat. 4192, and is codified in 46 U.S.C. 70112. The Committee
operates under the provisions of the Federal Advisory Committee Act, (5
U.S.C. Appendix), and 46 U.S.C. 15109. The National Maritime Security
Advisory Committee provides advice, consults with, and makes
recommendations to the Secretary of Homeland Security, via the
Commandant of the Coast Guard, on matters relating to national maritime
security.

Agenda

(1) Call to Order.
(2) Introduction.
(3) Designated Federal Official Remarks.
(4) Roll call of Committee members and determination of quorum.
(5) Update of task. The NMSAC will present an update on their work
to complete task T2021-01, Recommendations on Cybersecurity
Information Sharing.
(6) Presentation of task. The Coast Guard will present NMSAC with a
tasking concerning the Transportation Worker Identification
Credential.
(7) Public comment period.
(8) Closing Remarks/plans for next meeting.
(9) Adjournment of meeting.

    A copy of all pre-meeting documentation will be available at
https://homeport.uscg.mil/NMSAC by July 8, 2022. Alternatively, you may
contact Mr. Ryan Owens as noted in the FOR FURTHER INFORMATION CONTACT
section above.
    There will be a public comment period at the end of the meeting.
Speakers are requested to limit their comments to 3 minutes. Please
note that the public comment period may end before the period allotted,
following the last call for comments. Contact the individual listed in
the FOR FURTHER INFORMATION CONTACT section above to register as a
speaker.

    Dated: June 16, 2022.
Jason D. Neubauer,
Captain, U.S. Coast Guard, Acting Director of Inspections and
Compliance.
[FR Doc. 2022-13341 Filed 6-21-22; 8:45 am]
BILLING CODE 9110-04-P


[Federal Register Volume 78, Number 160 (Monday, August 19, 2013)]
[Notices]
[Pages 50486-50489]
[FR Doc No: 2013-20009]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2013-0182]

Qualification of Drivers; Exemption Applications; Diabetes
Mellitus

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of applications for exemption from the diabetes mellitus
requirement; request for comments.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces receipt of applications from 19 individuals
for exemption from the prohibition against persons with insulin-treated
diabetes mellitus (ITDM) operating commercial motor vehicles (CMVs) in
interstate commerce. If granted, the exemptions would enable these
individuals with ITDM to operate CMVs in interstate commerce.

DATES: Comments must be received on or before September 18, 2013.

ADDRESSES: You may submit comments bearing the Federal Docket
Management System (FDMS) Docket No. FMCSA-2013-0182 using any of the
following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the on-line instructions for submitting
comments.
     Mail: Docket Management Facility; U.S. Department of
Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery: West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal Holidays.
     Fax: 1-202-493-2251.
    Instructions: Each submission must include the Agency name and the
docket numbers for this notice. Note that all comments received will be
posted without change to http://www.regulations.gov, including any
personal information provided. Please see the Privacy Act heading below
for further information.
    Docket: For access to the docket to read background documents or
comments, go to http://www.regulations.gov at any time or Room W12-140
on the ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays. The Federal Docket Management System (FDMS) is
available 24 hours each day, 365 days each year. If you want
acknowledgment that we received your comments, please include a self-
addressed, stamped envelope or postcard or print the acknowledgement
page that appears after submitting comments on-line.
    Privacy Act: Anyone may search the electronic form of all comments
received into any of our dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, etc.).
You may review DOT's Privacy Act Statement for the Federal Docket
Management System (FDMS) published in the Federal Register on January
17, 2008 (73 FR 3316).

FOR FURTHER INFORMATION CONTACT: Elaine M. Papp, Chief, Medical
Programs Division,<PHONE_NUMBER><EMAIL_ADDRESS>FMCSA,
Department of Transportation, 1200 New Jersey Avenue SE., Room W64-224,
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m.,
Monday through Friday, except Federal holidays.

SUPPLEMENTARY INFORMATION:

Background

    Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the Federal Motor Carrier Safety Regulations for a 2-year period
if it finds ``such exemption would likely achieve a level of safety
that is equivalent to or greater than the level that would be achieved
absent such exemption.'' The statute also allows the Agency to renew
exemptions at the end of the 2-year period. The 19 individuals listed
in this notice have recently requested such an exemption from the
diabetes prohibition in 49 CFR 391.41(b) (3), which applies to drivers
of CMVs in interstate commerce. Accordingly, the Agency will evaluate
the qualifications of each applicant to determine whether granting the
exemption will achieve the required level of safety mandated by
statute.

Qualifications of Applicants

Francisco Barron

    Mr. Barron, 41, has had ITDM since 1985. His endocrinologist
examined him in 2012 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Barron understands diabetes
management and monitoring,

has stable control of his diabetes using insulin, and is able to drive
a CMV safely. Mr. Barron meets the vision requirements of 49 CFR
391.41(b)(10). His ophthalmologist examined him in 2013 and certified
that he has stable nonproliferative diabetic retinopathy and stable
proliferative diabetic retinopathy. He holds a Class C operator's
license from Texas.

Jase V. Burkhart

    Mr. Burkhart, 25, has had ITDM since 1995. His endocrinologist
examined him in 2013 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Burkhart understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Burkhart meets the
vision requirements of 49 CFR 391.41(b)(10). His ophthalmologist
examined him in 2013 and certified that he has stable nonproliferative
diabetic retinopathy. He holds a Class A CDL from South Dakota.

Peter Engel

    Mr. Engel, 42, has had ITDM since 2000. His endocrinologist
examined him in 2012 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Engel understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Engel meets the vision
requirements of 49 CFR 391.41(b)(10). His ophthalmologist examined him
in 2012 and certified that he has stable nonproliferative diabetic
retinopathy. He holds a Class A CDL from Pennsylvania.

Jhon A. Fitzgerald

    Mr. Fitzgerald, 47, has had ITDM since 2012. His endocrinologist
examined him in 2013 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Fitzgerald understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Fitzgerald meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2013 and certified that he has stable
non-proliferative diabetic retinopathy. He holds a Class B CDL from
Maine.

Lewis E. Forrester

    Mr. Forrester, 60, has had ITDM since 2009. His endocrinologist
examined him in 2013 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Forrester understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Forrester meets the
vision requirements of 49 CFR 391.41(b)(10). His ophthalmologist
examined him in 2013 and certified that he has stable nonproliferative
diabetic retinopathy. He holds a Class A CDL from Pennsylvania.

Randall G. Freed

    Mr. Freed, 59, has had ITDM since 2008. His endocrinologist
examined him in 2013 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Freed understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Freed meets the vision
requirements of 49 CFR 391.41(b)(10). His ophthalmologist examined him
in 2013 and certified that he does not have diabetic retinopathy. He
holds a Class D operator's license from Illinois.

Jesus A. Gonzales

    Mr. Gonzales, 49, has had ITDM since 2010. His endocrinologist
examined him in 2013 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Gonzales understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Gonzales meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2013 and certified that he does not have
diabetic retinopathy. He holds a Class D operator's license from New
York.

Robert D. Graves

    Mr. Graves, 69, has had ITDM since 2013. His endocrinologist
examined him in 2013 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Graves understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Graves meets the vision
requirements of 49 CFR 391.41(b)(10). His ophthalmologist examined him
in 2013 and certified that he does not have diabetic retinopathy. He
holds a Class A CDL from Iowa.

Michael G. Harp

    Mr. Harp, 38, has had ITDM since 2006. His endocrinologist examined
him in 2012 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Harp understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Harp meets the vision requirements
of 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2013 and
certified that he has stable nonproliferative diabetic retinopathy. He
holds a Class D operator's license from Oklahoma.

Ray Harrison

    Mr. Harrison, 29, has had ITDM since 1992. His endocrinologist
examined him in 2012 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the

assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Harrison understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Harrison meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2013 and certified that he has stable
non-proliferative diabetic retinopathy. He holds a Class C operator's
license from Maryland.

Edward E. Hartford

    Mr. Hartford, 43, has had ITDM since 2012. His endocrinologist
examined him in 2012 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Hartford understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Hartford meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2012 and certified that he has stable
non-proliferative diabetic retinopathy. He holds a Class A CDL from New
York.

Michael Hatfield

    Mr. Hatfield, 55, has had ITDM since 2013. His endocrinologist
examined him in 2013 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Hatfield understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Hatfield meets the
vision requirements of 49 CFR 391.41(b)(10). His ophthalmologist
examined him in 2013 and certified that he has stable proliferative
diabetic retinopathy. He holds a Class A CDL from Kentucky.

Charles LaBruno

    Mr. LaBruno, 53, has had ITDM since 2012. His endocrinologist
examined him in 2012 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. LaBruno understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. LaBruno meets the
vision requirements of 49 CFR 391.41(b)(10). His optometrist examined
him in 2013 and certified that he does not have diabetic retinopathy.
He holds a Class B CDL from Pennsylvania.

Clinton D. Lewis

    Mr. Lewis, 36, has had ITDM since 2011. His endocrinologist
examined him in 2012 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Lewis understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Lewis meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2012 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Iowa.

Shawn E. Marks

    Mr. Marks, 39, has had ITDM since 2005. His endocrinologist
examined him in 2013 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Marks understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Marks meets the vision
requirements of 49 CFR 391.41(b)(10). His optometrist examined him in
2012 and certified that he does not have diabetic retinopathy. He holds
a Class C operator's license from Pennsylvania.

John D. Patterson

    Mr. Patterson, 42, has had ITDM since 2010. His endocrinologist
examined him in 2013 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Patterson understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Patterson meets the
vision requirements of 49 CFR 391.41(b)(10). His optometrist examined
him in 2013 and certified that he does not have diabetic retinopathy.
He holds a Class A CDL from Ohio.

Ricky A. Root

    Mr. Root, 51, has had ITDM since 2012. His endocrinologist examined
him in 2013 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Root understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Root meets the vision requirements
of 49 CFR 391.41(b)(10). His optometrist examined him in 2013 and
certified that he does not have diabetic retinopathy. He holds a Class
A CDL from Illinois.

Tina M. Schreiber

    Ms. Schreiber, 43, has had ITDM since 2013. Her endocrinologist
examined her in 2013 and certified that she has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
Her endocrinologist certifies that Ms. Schreiber understands diabetes
management and monitoring, has stable control of her diabetes using
insulin, and is able to drive a CMV safely. Ms. Schreiber meets the
vision requirements of 49 CFR 391.41(b)(10). Her optometrist examined
her in 2013 and certified that she does not have diabetic retinopathy.
She holds a Class D operator's license from Minnesota.

Donald G. Staggs

    Mr. Staggs, 51, has had ITDM since 2009. His endocrinologist
examined him in 2013 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Staggs understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Staggs meets the vision
requirements of 49 CFR 391.41(b)(10). His optometrist examined him in
2013 and certified that he does not have diabetic retinopathy. He holds
a Class C operator's license from California.

Request for Comments

    In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests
public comment from all interested persons on the exemption petitions
described in this notice. We will consider all comments received before
the close of business on the closing date indicated in the date section
of the notice.
    FMCSA notes that section 4129 of the Safe, Accountable, Flexible
and Efficient Transportation Equity Act: A Legacy for Users requires
the Secretary to revise its diabetes exemption program established on
September 3, 2003 (68 FR 52441).\1\ The revision must provide for
individual assessment of drivers with diabetes mellitus, and be
consistent with the criteria described in section 4018 of the
Transportation Equity Act for the 21st Century (49 U.S.C. 31305).
---------------------------------------------------------------------------

    \1\ Section 4129(a) refers to the 2003 notice as a ``final
rule.'' However, the 2003 notice did not issue a ``final rule'' but
did establish the procedures and standards for issuing exemptions
for drivers with ITDM.
---------------------------------------------------------------------------

    Section 4129 requires: (1) Elimination of the requirement for 3
years of experience operating CMVs while being treated with insulin;
and (2) establishment of a specified minimum period of insulin use to
demonstrate stable control of diabetes before being allowed to operate
a CMV.
    In response to section 4129, FMCSA made immediate revisions to the
diabetes exemption program established by the September 3, 2003 notice.
FMCSA discontinued use of the 3-year driving experience and fulfilled
the requirements of section 4129 while continuing to ensure that
operation of CMVs by drivers with ITDM will achieve the requisite level
of safety required of all exemptions granted under 49 USC. 31136(e).
    Section 4129(d) also directed FMCSA to ensure that drivers of CMVs
with ITDM are not held to a higher standard than other drivers, with
the exception of limited operating, monitoring and medical requirements
that are deemed medically necessary.
    The FMCSA concluded that all of the operating, monitoring and
medical requirements set out in the September 3, 2003 notice, except as
modified, were in compliance with section 4129(d). Therefore, all of
the requirements set out in the September 3, 2003 notice, except as
modified by the notice in the Federal Register on November 8, 2005 (70
FR 67777), remain in effect.

Submitting Comments

    You may submit your comments and material online or by fax, mail,
or hand delivery, but please use only one of these means. FMCSA
recommends that you include your name and a mailing address, an email
address, or a phone number in the body of your document so that FMCSA
can contact you if there are questions regarding your submission.
    To submit your comment online, go to http://www.regulations.gov and
in the search box insert the docket number FMCSA-2013-0182 and click
the search button. When the new screen appears, click on the blue
``Comment Now!'' button on the right hand side of the page. On the new
page, enter information required including the specific section of this
document to which each comment applies, and provide a reason for each
suggestion or recommendation. If you submit your comments by mail or
hand delivery, submit them in an unbound format, no larger than 8\1/2\
by 11 inches, suitable for copying and electronic filing. If you submit
comments by mail and would like to know that they reached the facility,
please enclose a stamped, self-addressed postcard or envelope.
    We will consider all comments and material received during the
comment period and may change this proposed rule based on your
comments. FMCSA may issue a final rule at any time after the close of
the comment period.

Viewing Comments and Documents

    To view comments, as well as any documents mentioned in this
preamble, to submit your comment online, go to http://www.regulations.gov and in the search box insert the docket number
FMCSA-2013-0182 and click ``Search.'' Next, click ``Open Docket
Folder'' and you will find all documents and comments related to the
proposed rulemaking.

    Issued on: August 8, 2013.
Larry W. Minor,
 Associate Administrator for Policy.
[FR Doc. 2013-20009 Filed 8-16-13; 8:45 am]
BILLING CODE 4910-EX-P


[Federal Register Volume 78, Number 149 (Friday, August 2, 2013)]
[Notices]
[Pages 46966-46969]
[FR Doc No: 2013-18622]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2013-N-0007]

Food Safety Modernization Act Domestic and Foreign Facility
Reinspection, Recall, and Importer Reinspection Fee Rates for Fiscal
Year 2014

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the
fiscal year (FY) 2014 fee rates for certain domestic and foreign
facility reinspections, failures to comply with a recall order, and
importer reinspections that are authorized by the Federal Food, Drug,
and Cosmetic Act (the FD&C Act), as amended by the FDA Food Safety
Modernization Act (FSMA). These fees are effective on October 1, 2013,
and will remain in effect through September 30, 2014.

FOR FURTHER INFORMATION CONTACT: Hunter Herrman, Office of Resource
Management, Office of Regulatory Affairs, Food and Drug Administration,
12420 Parklawn Dr., rm. 2049, Rockville, MD 20857,<PHONE_NUMBER>, email:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Background

    Section 107 of FSMA (Pub. L. 111-353) added section 743 to the FD&C
Act (21 U.S.C. 379j-31) to provide FDA with the authority to assess and
collect fees from, in part: (1) The responsible party for each domestic
facility and the U.S. agent for each foreign facility subject to a
reinspection, to cover reinspection-related costs; (2) the responsible
party for a domestic facility and an importer who does not comply with
a recall order, to cover food \1\ recall activities associated with
such order; and (3) each importer subject to a reinspection to cover
reinspection-related costs (sections 743(a)(1)(A), (B), and (D) of the
FD&C Act). Section 743 of the FD&C Act directs FDA to establish fees
for each of these activities based on an estimate of 100 percent of the
costs of each activity for each year (section 743(b)(2)(A), (B), and
(D)), and these fees must be made available solely to pay for the costs
of each activity for which the fee was incurred (section 743(b)(3)).
These fees are effective on October 1, 2013, and will remain in effect
through September 30, 2014. Section 743(b)(2)(B)(iii) of the FD&C Act
directs FDA to develop a proposed set of guidelines in consideration of
the burden of fee amounts on small businesses. As a first step in
developing these guidelines, FDA invited public comment on the
potential impact of the fees authorized by section 743 of the FD&C Act
on small businesses (76 FR 45818, August 1, 2011). The comment period
for this request ended November 30, 2011. As stated in FDA's September
2011 ``Guidance for Industry: Implementation of the Fee Provisions of
Section 107 of the FDA Food Safety Modernization Act,'' (http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/FoodDefense/ucm274176.htm),
because FDA recognizes that for small businesses the full cost recovery
of FDA reinspection or recall oversight could impose severe economic
hardship, FDA intends to consider reducing certain fees for those
firms. FDA is currently developing a guidance document to outline the
process through which firms may request such a reduction of fees. FDA
does not intend to issue invoices for reinspection or recall order fees
until this guidance document has been published.
---------------------------------------------------------------------------

    \1\ The term ``food'' for purposes of this document has the same
meaning as such term in section 201(f) of the FD&C Act (21 U.S.C.
321(f)).
---------------------------------------------------------------------------

    In addition, as stated in the September 2011 Guidance, FDA is in
the process of considering various issues associated with the
assessment and collection of importer reinspection fees. FDA is
currently developing a guidance document that will provide information
regarding fees that the Agency may assess and collect from importers to
cover reinspection-related costs. The fee rates set forth in this
notice will be used to determine any importer reinspection fees
assessed in FY 2014.

II. Estimating the Average Cost of a Supported Direct FDA Work Hour for
FY 2014

    FDA is required to estimate 100 percent of its costs for each
activity in order to establish fee rates for FY 2014. In each year, the
costs of salary (or personnel compensation) and benefits for FDA
employees account for between 50 and 60 percent of the funds available
to, and used by, FDA. Almost all of the remaining funds (or the
operating funds) available to FDA are used to support FDA employees for
paying rent, travel, utility, information technology, and other
operating costs.

A. Estimating the Full Cost per Direct Work Hour in FY 2012

    In general, the starting point for estimating the full cost per
direct work hour is to estimate the cost of a full-time-equivalent
(FTE) or paid staff year for the relevant activity. This is most
reasonably done by dividing the total funds allocated to the elements
of FDA primarily responsible for carrying out the activities for which
fees are being collected by the total FTEs allocated to those
activities, using information from the most recent FY for which data
are available. For the purposes of the reinspection and recall order
fees authorized by section 743 of the FD&C Act (the fees that are the
subject of this notice), primary responsibility for the activities for
which fees will be collected rests with FDA's Office of Regulatory
Affairs (ORA), which carries out inspections and other field-based
activities on behalf of FDA's product centers, including the Center for
Food Safety and Applied Nutrition (CFSAN) and the Center for Veterinary
Medicine (CVM). Thus, as the starting point for estimating the full
cost per direct work hour, FDA will use the total funds allocated to
ORA for CFSAN and CVM related field activities. The most recent FY with
available data is FY 2012. In that year, FDA obligated a total of
$697,628,866 for ORA in carrying out the CFSAN and CVM related field
activities work, excluding the cost of inspection travel. In that same
year, the number of ORA staff primarily conducting the CFSAN and CVM
related field activities was 2,944 FTEs or paid staff years. Dividing
$697,628,866 by 2,944 FTEs, results in an average cost of $236,966 per
paid staff year, excluding travel costs.
    Not all of the FTEs required to support the activities for which
fees will be collected are conducting direct work such as inspecting or
reinspecting facilities, examining imports, or monitoring recalls. Data
collected over a number of years and used consistently in other FDA
user fee programs (e.g., under the Prescription Drug User Fee Act
(PDUFA) and the Medical Device User Fee and Modernization Act (MDUFA))
show that every seven FTEs who perform direct FDA work require three
indirect and supporting FTEs. These indirect and supporting FTEs
function in budget, facility, human resource, information technology,
planning, security, administrative support, legislative liaison, legal
counsel, program management, and other essential program areas. On
average, two of these indirect and supporting FTEs are located in ORA
or the FDA center where the direct work is being conducted, and one of
them is located in the Office of the Commissioner. To get the fully
supported cost of an FTE, FDA needs to multiply the average cost of an
FTE by 1.43, to take into account the indirect and supporting
functions. The 1.43 factor is derived by dividing the 10 fully
supported FTEs by 7 direct FTEs. In FY 2012, the average cost of an FTE
was $236,966. Multiplying this amount by 1.43 results in an average
fully supported cost of $338,861 per FTE, excluding the cost of
inspection travel.
    To calculate an hourly rate, FDA must divide the average fully
supported cost of $338,861 per FTE by the average number of supported
direct FDA work hours. See Table 1.

      Table 1--Supported Direct FDA Work Hours in a Paid Staff Year
------------------------------------------------------------------------

------------------------------------------------------------------------
Total number of hours in a paid staff year.....................    2,080
Less:                                                            .......
  10 paid holidays.............................................       80
  20 days of annual leave......................................      160
  10 days of sick leave........................................       80
  10 days of training..........................................       80
  2 hours of meetings per week.................................       80
                                                                --------
  Net Supported Direct FDA Work Hours Available for Assignments    1,600
------------------------------------------------------------------------

    Dividing the average fully supported cost of an FTE in FY 2012
($338,861) by the total number of supported direct work hours available
for assignment (1,600) results in an average fully supported cost of
$212 (rounded to the nearest dollar), excluding inspection travel
costs, per supported direct work hour in FY 2012--the last FY for which
data are available.

B. Adjusting FY 2012 Costs for Inflation To Estimate FY 2014 Costs

    To adjust the hourly rate for FY 2014, FDA must estimate the cost
of inflation in each year for FY 2013 and FY 2014. FDA uses the method
prescribed for estimating inflationary costs under the PDUFA provisions
of the FD&C Act (section 736(c)(1) (21 U.S.C. 379h(c)(1)), the
statutory method for inflation adjustment in the FD&C Act that we have
used consistently. FDA previously determined the FY 2013 inflation rate
to be 2.01 percent; this rate was published in the FY 2013 PDUFA user
fee rates notice in the Federal Register of August 1, 2012 (77 FR
45639). Utilizing the method set forth in section 736(c)(1) of the FD&C
Act, FDA has calculated an inflation rate of 2.20 percent for FY 2014
and FDA intends to use this inflation rate to make inflation
adjustments for FY 2014 for several of its user fee programs; the
derivation of this rate is published elsewhere in this issue of the
Federal Register in the FY 2014 notice for the PDUFA user fee rates.
The compounded inflation rate for FYs 2013 and 2014, therefore, is 4.25
percent (one plus 2.01 percent times one plus 2.20 percent).
    Increasing the FY 2012 average fully supported cost per supported
direct FDA work hour of $212 (excluding inspection travel costs) by
4.25 percent yields an inflationary adjusted estimated cost of $221 per
a supported direct work hour in FY 2014, excluding inspection travel
costs. This is the base unit fee that FDA will use in determining the
hourly fee rate for reinspection and recall order fees for FY 2014,
prior to including domestic or foreign travel costs as applicable for
the activity.
    In FY 2012, ORA spent a total of $5,399,442 for domestic regulatory
inspection travel costs and General Services Administration Vehicle
costs related to FDA's CFSAN and CVM field activities programs. The
total ORA domestic travel costs spent is then divided by the total of
12,302 CFSAN and CVM domestic inspections, which averages a total of
$439 per inspection. These inspections average 29.19 hours per
inspection. Dividing $439 per inspection by 29.19 hours per inspection
results in a total and an additional cost of $15 per hour spent for
domestic inspection travel costs in FY 2012. To adjust $15 for
inflationary increases in FY 2013 and FY 2014, FDA must multiply it by
the same inflation factor mentioned previously in this document
(1.0425) which results in an estimated cost of $16 dollars per paid
hour in addition to $221 for a total of $237 per paid hour ($221 plus
$16) for each direct hour of work requiring domestic inspection travel.
These are the rates that FDA will use in charging fees in FY 2014 when
domestic travel is required.
    In FY 2012, ORA spent a total of $2,831,056 on a total of 301
foreign inspection trips related to FDA's CFSAN and CVM field
activities programs, which averaged a total of $9,406 per foreign
inspection trip. These trips averaged 3 weeks (or 120 paid hours) per
trip. Dividing $9,406 per trip by 120 hours per trip results in a total
and an additional cost of $78 per paid hour spent for foreign
inspection travel costs in FY 2012. To adjust $78 for inflationary
increases in FY 2013 and FY 2014, FDA must multiply it by the same
inflation factor mentioned previously in this document (1.0425) which
results in an estimated cost of

$81 dollars per paid hour in addition to $221 for a total of $302 per
paid hour ($221 plus $81) for each direct hour of work requiring
foreign inspection travel. These are the rates that FDA will use in
charging fees in FY 2014 when foreign travel is required.

                 Table 2--FSMA Fee Schedule for FY 2014
------------------------------------------------------------------------
                                                               Fee rates
                        Fee category                            for FY
                                                                 2014
------------------------------------------------------------------------
Hourly rate if domestic travel is required..................        $237
Hourly rate if foreign travel is required...................         302
------------------------------------------------------------------------

III. Fees for Reinspections of Domestic or Foreign Facilities Under
Section 743(a)(1)(A)

A. What will cause this fee to be assessed?

    The fee will be assessed for a reinspection conducted under section
704 of the FD&C Act (21 U.S.C. 374) to determine whether corrective
actions have been implemented and are effective and compliance has been
achieved to the Secretary of Health and Human Services' (the Secretary)
(and, by delegation, FDA's) satisfaction at a facility that
manufactures, processes, packs or holds food for consumption
necessitated as a result of a previous inspection (also conducted under
section 704) of this facility which had a final classification of
Official Action Indicated (OAI) conducted by or on behalf of FDA, when
FDA determined the non-compliance was materially related to food safety
requirements of the FD&C Act. FDA considers such non-compliance to
include non-compliance with a statutory or regulatory requirement under
section 402 of the FD&C Act (21 U.S.C. 342) and section 403(w) of the
FD&C Act (21 U.S.C. 343(w)). However, FDA does not consider non-
compliance that is materially related to a food safety requirement to
include circumstances where the non-compliance is of a technical nature
and not food safety related (e.g., failure to comply with a food
standard or incorrect font size on a food label). Determining when non-
compliance, other than under sections 402 and 403(w) of the FD&C Act,
is materially related to a food safety requirement of the FD&C Act may
depend on the facts of a particular situation. FDA intends to issue
guidance to provide additional information about the circumstances
under which FDA would consider non-compliance to be materially related
to a food safety requirement of the FD&C Act.
    Under section 743(a)(1)(A) of the FD&C Act, FDA is directed to
assess and collect fees from ``the responsible party for each domestic
facility (as defined in section 415(b) (21 U.S.C. 350d)) and the United
States agent for each foreign facility subject to a reinspection'' to
cover reinspection-related costs.
    Section 743(a)(2)(A)(i) of the FD&C Act defines the term
``reinspection'' with respect to domestic facilities as ``1 or more
inspections conducted under section 704 subsequent to an inspection
conducted under such provision which identified non-compliance
materially related to a food safety requirement of th[e] Act,
specifically to determine whether compliance has been achieved to the
Secretary's satisfaction.''
    The FD&C Act does not contain a definition of ``reinspection''
specific to foreign facilities. In order to give meaning to the
language in section 743(a)(1)(A) of the FD&C Act to collect fees from
the U.S. agent of a foreign facility subject to a reinspection, the
Agency is using the following definition of ``reinspection'' for
purposes of assessing and collecting fees under section 743(a)(1)(A),
with respect to a foreign facility: ``1 or more inspections conducted
by officers or employees duly designated by the Secretary subsequent to
such an inspection which identified non-compliance materially related
to a food safety requirement of the FD&C Act, specifically to determine
whether compliance has been achieved to the Secretary's (and, by
delegation, FDA's) satisfaction.''
    This definition allows FDA to fulfill the mandate to assess and
collect fees from the U.S. agent of a foreign facility in the event
that an inspection reveals non-compliance materially related to a food
safety requirement of the FD&C Act, causing one or more subsequent
inspections to determine whether compliance has been achieved to the
Secretary's (and, by delegation, FDA's) satisfaction. By requiring the
initial inspection to be conducted by officers or employees duly
designated by the Secretary, the definition ensures that a foreign
facility would be subject to fees only in the event that FDA, or an
entity designated to act on its behalf, has made the requisite
identification at an initial inspection of non-compliance materially
related to a food safety requirement of the FD&C Act. The definition of
``reinspection-related costs'' in section 743(a)(2)(B) of the FD&C Act
relates to both a domestic facility reinspection and a foreign facility
reinspection, as described in section 743(a)(1)(A).

B. Who will be responsible for paying this fee?

    The FD&C Act states that this fee is to be paid by the responsible
party for each domestic facility (as defined in section 415(b) of the
FD&C Act) and by the U.S. agent for each foreign facility (section
743(a)(1)(A) of the FD&C Act). This is the party to whom FDA will send
the invoice for any fees that are assessed under this section.

C. How much will this fee be?

    The fee is based on the number of direct hours spent on such
reinspections, including time spent conducting the physical
surveillance and/or compliance reinspection at the facility, or
whatever components of such an inspection are deemed necessary, making
preparations and arrangements for the reinspection, traveling to and
from the facility, preparing any reports, analyzing any samples or
examining any labels if required, and performing other activities as
part of the OAI reinspection until the facility is again determined to
be in compliance. The direct hours spent on each such reinspection will
be billed at the appropriate hourly rate shown in table 2 of this
document.

IV. Fees for Non-Compliance With a Recall Order Under Section
743(a)(1)(B)

A. What will cause this fee to be assessed?

    The fee will be assessed for not complying with a recall order
under section 423(d) (21 U.S.C. 350l(d)) or section 412(f) of the FD&C
Act (21 U.S.C. 350a(f)) to cover food recall activities associated with
such order performed by the Secretary (and by delegation, FDA) (section
743(a)(1)(B) of the FD&C Act). Non-compliance may include the
following: (1) Not initiating a recall as ordered by FDA; (2) not
conducting the recall in the manner specified by FDA in the recall
order; or (3) not providing FDA with requested information regarding
the recall, as ordered by FDA.

B. Who will be responsible for paying this fee?

    Section 743(a)(1)(B) of the FD&C Act states that the fee is to be
paid by the responsible party for a domestic facility (as defined in
section 415(b) of the FD&C Act) and an importer who does not comply
with a recall order under section 423 or under section 412(f) of the
FD&C Act. In other words, the party paying the fee would be the party
that received the recall order.

C. How much will this fee be?

    The fee is based on the number of direct hours spent on taking
action in response to the firm's failure to comply with a recall order.
Types of activities could include conducting recall audit checks,
reviewing periodic status reports, analyzing the status reports and the
results of the audit checks, conducting inspections, traveling to and
from locations, and monitoring product disposition. The direct hours
spent on each such recall will be billed at the appropriate hourly rate
shown in table 2 of this document.

V. How must the fees be paid?

    An invoice will be sent to the responsible party for paying the fee
after FDA completes the work on which the invoice is based. Payment
must be made within 90 days of the invoice date in U.S. currency by
check, bank draft, or U.S. postal money order payable to the order of
the Food and Drug Administration. Detailed payment information will be
included with the invoice when it is issued.

VI. What are the consequences of not paying these fees?

    Under section 743(e)(2) of the FD&C Act, any fee that is not paid
within 30 days after it is due shall be treated as a claim of the U.S.
Government subject to provisions of subchapter II of chapter 37 of
title 31, United States Code.

    Dated: July 29, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-18622 Filed 8-1-13; 8:45 am]
BILLING CODE 4160-01-P


[Federal Register: May 16, 2008 (Volume 73, Number 96)]
[Notices]
[Page 28530-28531]
[DOCID:fr16my08-119]

-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Occupational Safety and Health Administration

[Docket No. OSHA-2008-0002]

National Advisory Committee on Occupational Safety and Health
(NACOSH); Announcement of Meeting

AGENCY: Occupational Safety and Health Administration (OSHA), Labor.

ACTION: Announcement of meeting.

-----------------------------------------------------------------------

SUMMARY: The National Advisory Committee on Occupational Safety and
Health (NACOSH) will meet May 29, 2008, in Washington, DC.

DATES: NACOSH meeting: NACOSH will meet from 9 a.m. to 4 p.m.,
Thursday, May 29, 2008.
    Submission of comments and requests to speak: Comments and requests
to speak at the NACOSH meeting must be received by Thursday, May 22,
2008.

ADDRESSES: NACOSH meeting: NACOSH will meet in Room N-3437 A/B/C/D,
U.S. Department of Labor, 200 Constitution Avenue, NW., Washington, DC
20210.
    Submission of comments and requests to speak: Comments and requests
to speak at the NACOSH meeting, identified by docket number for this
Federal Register notice (Docket No. OSHA-2008-0002), may be submitted
by any of the following methods:
    Electronically: You may submit materials, including attachments,
electronically at: http://www.regulations.gov, the Federal eRulemaking
Portal. Follow the online instructions for making submissions.
    Facsimile: If your submission, including attachments, does not
exceed 10 pages, you may fax it to the OSHA Docket Office at (202) 693-
1648.
    Mail, express delivery, hand delivery, messenger or courier
service: Submit three copies of your submissions to the OSHA Docket
Office, Room N-2625, U.S. Department of Labor, 200 Constitution Avenue,
NW., Washington, DC 20210, telephone<PHONE_NUMBER> (TTY (877) 889-
5627). Deliveries (hand, express mail, messenger and courier service)
are accepted during the Department of Labor's and OSHA Docket Office's
normal business hours, 8:15 a.m. to 4:45 p.m., et.
    Instructions: All submissions must include the Agency name and
docket number for this Federal Register notice (Docket No. OSHA-2008-
0002). Submissions in response to this notice, including personal
information provided, will be posted without change at
http:www.regulations.gov. Therefore, OSHA cautions interested parties
about submitting personal information such as social security numbers
and birth dates. Because of security-related procedures, submissions by
regular mail may result in a significant delay in their receipt. Please
contact the OSHA Docket Office, at the address above, for information
about security procedures concerning submitting materials by hand
delivery, express delivery, and messenger or courier service. For
additional information on submitting comments and requests to speak,
see the SUPPLEMENTARY INFORMATION section below.
    Docket: To read or download submissions, go to http://
www.regulations.gov. Although listed in the index, some documents
(e.g., copyrighted material) are not publicly available to read or
download through http://www.regulations.gov. All submissions, including
copyrighted material, are available for inspection

and copying at the OSHA Docket Office at the address above.

FOR FURTHER INFORMATION CONTACT: For general information: Deborah
Crawford, OSHA, Directorate of Evaluation and Analysis, U.S. Department
of Labor, Room N-3641, 200 Constitution Avenue, NW., Washington, DC
20210; telephone<PHONE_NUMBER>; fax<PHONE_NUMBER>; e-mail
<EMAIL_ADDRESS>    For special accommodations for the NACOSH meeting: Veneta Chatmon,
OSHA, Office of Communications, Room N-3647, U.S. Department of Labor,
200 Constitution Avenue, NW., Washington, DC 20210; telephone (202)
693-1999; e-mail<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: NACOSH will meet Thursday, May 29, 2008, in
Washington, DC. All NACOSH meetings are open to the public.
    Section 7(a) of the Occupational Safety and Health Act of 1970 (OSH
Act) (29 U.S.C. 656) authorizes NACOSH to advise the Secretary of Labor
and the Secretary of Health and Human Services on matters relating to
the administration of the OSH Act. NACOSH is a continuing advisory body
and operates in compliance with provisions in the OSH Act, the Federal
Advisory Committee Act (5 U.S.C. App. 2), and regulations issued
pursuant to those laws (29 CFR 1912a, 41 CFR part 101-6 and 102-3).
    The tentative agenda for the NACOSH meeting includes presentations
on the following:
     Public and municipal employees;
     Global harmonization;
     Aging workforce;
     Motor vehicle safety; and
     Worklife Initiative.
    NACOSH meetings are transcribed and detailed minutes of the
meetings are prepared. Meeting transcripts and minutes are included in
the official record of NACOSH meetings (Docket No OSHA-2008-0002).
    Interested parties may submit a request to make an oral
presentation to NACOSH by one of the methods listed in the ADDRESSES
section above. The request must state the amount of time requested to
speak, the interest represented (e.g., organization name), if any, and
a brief outline of the presentation. Requests to address NACOSH may be
granted as time permits and at the discretion of the NACOSH chair.
    Interested parties also may submit comments, including data and
other information using any of the methods listed in the ADDRESSES
section above. OSHA will provide all submissions to NACOSH members.
    Individuals who need special accommodation to attend the NACOSH
meeting should contact Veneta Chatmon, at the address above, at least
seven days before the meeting.

Public Participation--Submissions and Access to Official Meeting Record

    You may submit comments and requests to speak (1) electronically,
(2) by facsimile, or (3) by hard copy. All submissions, including
attachments and other materials, must identify the Agency name and the
docket number for this notice (Docket No. OSHA-2008-20002). You may
supplement electronic submissions by uploading documents
electronically. If, instead, you wish to submit hard copies of
supplementary documents, you must submit three copies to the OSHA
Docket Office using the instructions in the ADDRESSES section above.
The additional materials must clearly identify your electronic
submission by name, date and docket number.
    Because of security-related procedures, the use of regular mail may
cause a significant delay in the receipt of submissions. For
information about security procedures concerning submissions by hand,
express delivery, messenger or courier service, please contact the OSHA
Docket Office at<PHONE_NUMBER> (TTY<PHONE_NUMBER>).
    Meeting transcripts and minutes as well as submissions in response
to this Federal Register notice are included in the official record of
the NACOSH meeting (Docket No. OSHA-2008-0002). Submissions are posted
without change at http://www.regulations.gov. Therefore, OSHA cautions
interested parties about submitting personal information such as social
security numbers and birth dates. Although all submissions are listed
in the http://www.regulations.gov index, some documents (e.g.,
copyrighted materials) are not publicly available to read or download
through http://www.regulations.gov. All submissions, including
copyrighted material, are available for inspection and copying at the
OSHA Docket Office.
    Information on using the http://www.regulations.gov Web site to
make submissions and to access the docket and exhibits is available at
the Web site's User Tips link. Contact the OSHA Docket Office for
information about materials not available through the Web site and for
assistance in using the Internet to locate submissions and other
documents in the docket. Electronic copies of this Federal Register
notice are available at http://www.regulations.gov. This notice, as
well as news releases and other relevant information, is also available
on the OSHA Web page at http://www.osha.gov.

Authority and Signature

    Edwin G. Foulke, Jr., Assistant Secretary of Labor for Occupational
Safety and Health, directed the preparation of this notice under the
authority granted by section 7 of the Occupational Safety and Health
Act of 1970 (29 U.S.C. 656), 29 CFR 1912a, the Federal Advisory
Committee Act (5 U.S.C. App. 2), and Secretary of Labor's Order No. 5-
2007 (72 FR 31160).

    Signed at Washington, DC, this 13th day of May 2008.
Edwin G. Foulke, Jr.,
Assistant Secretary of Labor for Occupational Safety and Health.
 [FR Doc. E8-10995 Filed 5-15-08; 8:45 am]

BILLING CODE 4510-26-P


[Federal Register: July 26, 2006 (Volume 71, Number 143)]
[Notices]
[Page 42371]
[DOCID:fr26jy06-47]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. RP02-361-061]

Gulfstream Natural Gas System, L.L.C.; Notice of Filing

July 19, 2006.
    Take notice that on July 13, 2006, Gulfstream Natural Gas System,
L.L.C. (Gulfstream) tendered for filing as part of its FERC Gas Tariff,
Original Volume No. 1, First Revised Sheet Nos. 8.01t and 8.01z,
reflecting effective dates of September 15, 2005, and March 1, 2006,
respectively.
    Gulfstream states that copies of its filing have been mailed to all
affected customers and interested state commissions.
    Any person desiring to protest this filing must file in accordance
with Rule 211 of the Commission's Rules of Practice and Procedure (18
CFR 385.211). Protests to this filing will be considered by the
Commission in determining the appropriate action to be taken, but will
not serve to make protestants parties to the proceeding. Such protests
must be filed in accordance with the provisions of section 154.210 of
the Commission's regulations (18 CFR 154.210). Anyone filing a protest
must serve a copy of that document on all the parties to the
proceeding.
    The Commission encourages electronic submission of protests in lieu
of paper using the ``eFiling'' link at http://www.ferc.gov. Persons

unable to file electronically should submit an original and 14 copies
of the protest to the Federal Energy Regulatory Commission, 888 First
Street, NE., Washington, DC 20426.
    This filing is accessible on-line at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.

Magalie R. Salas,
Secretary.
[FR Doc. E6-11890 Filed 7-25-06; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 85, Number 143 (Friday, July 24, 2020)]
[Notices]
[Pages 44920-44921]
[FR Doc No: 2020-16106]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Internal Agency Docket No. FEMA-4494-DR; Docket ID FEMA-2020-0001]

Michigan; Amendment No. 1 to Notice of a Major Disaster
Declaration

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice amends the notice of a major disaster declaration
for the State of Michigan (FEMA-4494-DR), dated March 27, 2020, and
related determinations.

DATES: This change occurred on July 6, 2020.

FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and
Recovery, Federal Emergency Management Agency, 500 C Street SW,
Washington, DC 20472,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: The Federal Emergency Management Agency

(FEMA) hereby gives notice that pursuant to the authority vested in the
Administrator, under Executive Order 12148, as amended, Kevin M. Sligh,
of FEMA is appointed to act as the Federal Coordinating Officer for
this disaster.
    This action terminates the appointment of James K. Joseph as
Federal Coordinating Officer for this disaster.

The following Catalog of Federal Domestic Assistance Numbers (CFDA)
are to be used for reporting and drawing funds: 97.030, Community
Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis Counseling;
97.033, Disaster Legal Services; 97.034, Disaster Unemployment
Assistance (DUA); 97.046, Fire Management Assistance Grant; 97.048,
Disaster Housing Assistance to Individuals and Households In
Presidentially Declared Disaster Areas; 97.049, Presidentially
Declared Disaster Assistance--Disaster Housing Operations for
Individuals and Households; 97.050, Presidentially Declared Disaster
Assistance to Individuals and Households--Other Needs; 97.036,
Disaster Grants--Public Assistance (Presidentially Declared
Disasters); 97.039, Hazard Mitigation Grant.

Pete Gaynor,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2020-16106 Filed 7-23-20; 8:45 am]
BILLING CODE 9111-23-P


[Federal Register Volume 83, Number 131 (Monday, July 9, 2018)]
[Notices]
[Pages 31743-31744]
[FR Doc No: 2018-14556]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP18-6-000]

RH energytrans, LLC; Notice of Availability of the Environmental
Assessment for the Proposed Risberg Line Project

    The staff of the Federal Energy Regulatory Commission (FERC or
Commission) has prepared an environmental assessment (EA) for the
Risberg Line Project proposed by RH energytrans, LLC (RH) in the above-
referenced docket. RH requests authorization to construct, modify, own,
operate, and maintain natural gas facilities in Pennsylvania and Ohio
to provide 55,000 dekatherms per day of firm natural gas transportation
service.
    The EA assesses the potential environmental effects of the
construction and operation of the Risberg Line Project in accordance
with the requirements of the National Environmental Policy Act (NEPA).
The FERC staff concludes that approval of the proposed project, with
appropriate mitigating measures, would not constitute a major federal
action significantly affecting the quality of the natural and human
environment.
    The U.S. Army Corps of Engineers and the Pennsylvania Fish and Boat
Commission participated as cooperating agencies in the preparation of
the EA. Cooperating agencies have jurisdiction by law or special
expertise with respect to resources potentially affected by the
proposal and participate in the NEPA analysis. The U.S. Army Corps of
Engineers will adopt the EA to fulfill their agency's NEPA obligations
and will use the EA and supporting documentation to consider the
issuance of Clean Water Act Section 404 and Rivers and Harbors Act
Section 10 permits.
    The Risberg Line Project would consist of the following actions in
Pennsylvania:
     Minor modification at the existing County Line Compressor
Station in Erie County;
     installation of compression (approximately 728 horsepower,
natural gas-fired), receipt metering, and appurtenant facilities at the
existing (currently vacant) Meadville Compressor Station site in
Crawford County;
     re-certification and use of an existing 12-inch-diameter
pipeline extending 26.6 miles from the Meadville Compressor Station
north to an existing valve set in Washington Township, Erie County,
including construction of a new launcher/receiver;
     next to the Meadville Compressor Station, construction of
a 650-foot lateral within the existing 12-inch-diameter pipeline right-
of-way to move gas from the Tennessee Gas Pipeline Company, LLC system
to the existing pipeline; and
     re-certification and use of a portion of an existing 8-
inch-diameter pipeline extending from the 12-inch valve set west about
5.0 miles to a point in Elk Creek Township, Erie County (Line 10257),
including construction of two new launchers/receivers.
    In Pennsylvania and Ohio, the project would include:
     Construction of 28.3 miles of new 12-inch-diameter
pipeline from the west end of the recertified 8-inch-diameter pipeline
to connect with Dominion Energy Ohio facilities located in North
Kingsville, Ashtabula County, Ohio (Risberg Pipeline). The pipeline
would be constructed in new rights-of-way and include launcher/receiver
facilities and mainline valves; and
     construction of a new meter station at the terminus of the
new pipeline in North Kingsville, Ashtabula County, Ohio.
    The FERC staff mailed copies of the EA to federal, state, and local
government representatives and agencies; elected officials;
environmental and public interest groups; Native American tribes;
potentially affected landowners and other interested individuals and
groups; and newspapers and libraries in the project area. In addition,
the EA is available for public viewing on the FERC's website
(www.ferc.gov) using the eLibrary link. A limited number of copies of
the EA are available for distribution and public inspection at: Federal
Energy Regulatory Commission,

Public Reference Room, 888 First Street NE, Room 2A, Washington, DC
20426,<PHONE_NUMBER>.
    Any person wishing to comment on the EA may do so. Your comments
should focus on the potential environmental effects, reasonable
alternatives, and measures to avoid or lessen environmental impacts.
The more specific your comments, the more useful they will be. To
ensure that the Commission has the opportunity to consider your
comments prior to making its decision on this project, it is important
that we receive your comments in Washington, DC on or before 5:00pm
Eastern Time on July 30, 2018.
    For your convenience, there are three methods you can use to file
your comments to the Commission. In all instances, please reference the
project docket number (CP18-6-000) with your submission. The Commission
encourages electronic filing of comments and has staff available to
assist you at<PHONE_NUMBER> or [email protected].
    (1) You can file your comments electronically using the eComment
feature on the Commission's website (www.ferc.gov) under the link to
Documents and Filings. Using eComment is an easy method for submitting
brief, text-only comments on a project;
    (2) You can also file your comments electronically using the
eFiling feature on the Commission's website (www.ferc.gov) under the
link to Documents and Filings. With eFiling, you can provide comments
in a variety of formats by attaching them as a file with your
submission. New eFiling users must first create an account by clicking
on ``eRegister.'' You must select the type of filing you are making. A
comment on a particular project is considered a ``Comment on a
Filing''; or
    (3) You can file a paper copy of your comments by mailing them to
the following address: Kimberly D. Bose, Secretary, Federal Energy
Regulatory Commission, 888 First Street NE, Room 1A, Washington, DC
20426.
    Any person seeking to become a party to the proceeding must file a
motion to intervene pursuant to Rule 214 of the Commission's Rules of
Practice and Procedures (18 CFR 385.214). Only intervenors have the
right to seek rehearing or judicial review of the Commission's
decision. The Commission grants affected landowners and others with
environmental concerns intervenor status upon showing good cause by
stating that they have a clear and direct interest in this proceeding
which no other party can adequately represent. Simply filing
environmental comments will not give you intervenor status, but you do
not need intervenor status to have your comments considered.
    Additional information about the project is available from the
Commission's Office of External Affairs, at (866) 208-FERC, or on the
FERC website (www.ferc.gov) using the eLibrary link. Click on the
eLibrary link, click on ``General Search,'' and enter the docket number
in the ``Docket Number'' field, excluding the last three digits (i.e.,
CP18-6). Be sure you have selected an appropriate date range. For
assistance, please contact FERC Online Support at
[email protected] or toll free at<PHONE_NUMBER>, or for TTY,
contact<PHONE_NUMBER>. The eLibrary link also provides access to the
texts of all formal documents issued by the Commission, such as orders,
notices, and rulemakings.
    In addition, the Commission offers a free service called
eSubscription which allows you to keep track of all formal issuances
and submittals in specific dockets. This can reduce the amount of time
you spend researching proceedings by automatically providing you with
notification of these filings, document summaries, and direct links to
the documents. Go to www.ferc.gov/docs-filing/esubscription.asp.

    Dated: June 29, 2018.
Kimberly D. Bose,
Secretary.
[FR Doc. 2018-14556 Filed 7-6-18; 8:45 am]
 BILLING CODE 6717-01-P


[Federal Register: August 2, 2006 (Volume 71, Number 148)]
[Notices]
[Page 43722]
[DOCID:fr02au06-44]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 12581-001]

Cambria Somerset Authority; Notice of Surrender of Preliminary
Permit

July 26, 2006.
    Take notice that Cambria Somerset Authority, permittee for the
proposed Que Pumped Storage Project, has requested that its preliminary
permit be terminated. The permit was issued on December 15, 2005, and
would have expired on November 30, 2008.\1\ The project would have been
located on the Quemahoning Creek, in Somerset County, Pennsylvania.
---------------------------------------------------------------------------

    \1\ 113 FERC ] 62,214.
---------------------------------------------------------------------------

    The permittee filed the request on July 14, 2006, and the
preliminary permit for Project No. 12581 shall remain in effect through
the thirtieth day after issuance of this notice unless that day is a
Saturday, Sunday, part-day holiday that affects the Commission, or
legal holiday as described in section 18 CFR 385.2007, in which case
the effective date is the first business day following that day. New
applications involving this project site, to the extent provided for
under 18 CFR part 4, may be filed on the next business day.

Magalie R. Salas,
Secretary.
 [FR Doc. E6-12378 Filed 8-1-06; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 83, Number 195 (Tuesday, October 9, 2018)]
[Notices]
[Pages 50740-50741]
[FR Doc No: 2018-21886]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Agency Information Collection Activities: Requests for Comments;
Clearance of Renewed Approval of Information Collection: 2120-0043

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Paperwork Reduction Act of 1995, FAA
invites public comments about our intention to request the Office of
Management and Budget (OMB) approval to renew an information
collection. The collection involves return to the Civil Aviation
Aircraft Registry of information relating to the release of a lien that
has been recorded with the Registry. Regulations provide for
establishing and maintaining a system for the recording of security
conveyances affecting title to, or interest in U.S. civil aircraft, as
well as certain specifically identified engines, propellers, or spare
parts locations, and for recording of releases relating to those
conveyances. Federal Aviation Regulations establish procedures for
implementation. Regulations describe what information must be contained
in a security conveyance in order for it to

be recorded with FAA. The convention on the International Recognition
signatory, prevents, by treaty, the export of an aircraft and
cancellation of its nationality marks if there is an outstanding lien
recorded. The Civil Aviation Registry must have consent or release of
lien from the lienholder prior to confirmation/cancellation for export.

DATES: Written comments should be submitted by December 10, 2018.

ADDRESSES: Send comments to the FAA at the following address: Barbara
Hall, Federal Aviation Administration, ASP-110, 10101 Hillwood Parkway,
Fort Worth, TX 76177.
    Public Comments Invited: You are asked to comment on any aspect of
this information collection, including (a) Whether the proposed
collection of information is necessary for FAA's performance; (b) the
accuracy of the estimated burden; (c) ways for FAA to enhance the
quality, utility and clarity of the information collection; and (d)
ways that the burden could be minimized without reducing the quality of
the collected information. The agency will summarize and/or include
your comments in the request for OMB's clearance of this information
collection.

FOR FURTHER INFORMATION CONTACT: Barbara Hall by email at:
[email protected]; phone:<PHONE_NUMBER>

SUPPLEMENTARY INFORMATION:
    OMB Control Number: 2120-0043.
    Title: Recording of Aircraft Conveyances and Security Documents.
    Form Numbers: AC 8050-41, Notice of Recordation.
    Type of Review: For Renewal.
    Background: The single form (AC Form 8050-41, Notice of
Recordation) of the collection is sent to the lienholder when the
Registry records the lien on aircraft, propeller(s), engine(s) and/or
spare parts location(s). When the lien is satisfied, the lienholder
completes Part II of the form and returns it to the Registry as
official notification of the release of the lien. The collection
involves return to the Civil Aviation Aircraft Registry of information
relating to the release of a lien that has been recorded with the
Registry. Title 49, U.S.C. Section 44108 provides for establishing and
maintaining a system for the recording of security conveyances
affecting title to, or interest in U.S. civil aircraft, as well as
certain specifically identified engines, propellers, or spare parts
locations, and for recording of releases relating to those conveyances.
Federal Aviation Regulations Part 49 (14 CFR 49) establishes procedures
for implementation of 49 U.S.C. 44108. Part 49 describes what
information must be contained in a security conveyance in order for it
to be recorded with FAA.
    Respondents: Any aircraft, propeller or engine lienholder, who has
received the Notice of Recordation from the Registry, who is releasing
the subject lien.
    Frequency: The activity frequency is not predictable.
    Estimated Average Burden per Response: 1 hour.
    Estimated Total Annual Burden: For FY 2017, records indicate a
return of 23,681 release notifications for a total time burden of
approximately 23,681 hours.

    Issued in Washington, DC, on September 28, 2018.
Barbara L. Hall,
FAA Information Collection Clearance Officer, Performance, Policy, and
Records Management Branch, ASP-110.
[FR Doc. 2018-21886 Filed 10-5-18; 8:45 am]
 BILLING CODE 4910-13-P